Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.
Clinical trial NCT07420985 · RECRUITING
Trial details
- NCT number
- NCT07420985
- Sponsor
- Valenta Pharm JSC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-24
- Primary completion
- 2027-12-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.